Company profile: BTG
1.1 - Company Overview
Company description
- Provider of interventional medicine, pharmaceuticals, and licensing solutions, acquiring, developing, manufacturing, and commercializing products globally. Interventional oncology offerings include beads and TheraSphere Y-90 Glass Microspheres for HCC; other devices include Jetstream Atherectomy System, Vercise Genus DBS, Varithena 1% foam, WaveWriter Alpha SCS, and AcuPulse DUO CO2 Laser.
Products and services
- Jetstream Atherectomy System: A peripheral-artery–focused device that treats blockages by removing plaque, calcium, and thrombus
- TheraSphere Y-90 Glass Microspheres: A Y-90–based, glass microsphere therapy that delivers high-dose radiation to hepatocellular carcinoma tumors while preserving healthy tissue
- Varithena (polidocanol injectable foam) 1%: A foam-based, 1% polidocanol formulation used to treat varicose veins and improve symptoms of venous incompetence
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BTG
BiO2 Medical
HQ: United States
Website
- Description: Provider of the Angel Catheter that provides prophylactic pulmonary embolism protection and access to the central venous system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BiO2 Medical company profile →
Excision Medical
HQ: United States
Website
- Description: Provider of tools for TAVR procedures focused on safe, reliable leaflet modification and excision, device steering, and temporary hemodynamic support. Offerings include the Leaflet Excision System to target and excise aortic valve leaflets and mitigate risks during redo TAVR, Stýri steering catheters, Viking RF Excision Catheter, and HemoShield temporary valve.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Excision Medical company profile →
Proxim Diagnostics
HQ: United States
Website
- Description: Provider of next-generation handheld immunodiagnostic solutions, including a portable device for near-patient whole blood testing with touch-screen and multiple connectivity options, low-cost disposable test cartridges, and a test menu for sepsis, cardiology, and infectious disease (e.g., PCT). Suitable for emergency rooms, ICU, nursing and home care, community and employee clinics, rural and remote clinics, disaster relief, and defense.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Proxim Diagnostics company profile →
EKOS
HQ: United States
Website
- Description: Provider of ultrasound-accelerated thrombolysis systems for the treatment of vascular thrombosis. Its EKOS EkoSonic Endovascular System, introduced in 2005, is used by interventional radiologists, cardiologists, and vascular surgeons at leading institutions worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EKOS company profile →
Defibtech
HQ: United States
Website
- Description: Provider of automated external defibrillators and resuscitation devices, including Lifeline AED for public access and healthcare facilities, Lifeline ECG AED with dual AED mode and real-time ECG waveform display for healthcare providers and professional rescuers, and automated chest compression systems (ARM XR ACC and Lifeline ARM ACC) delivering continuous mechanical CPR for EMS use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Defibtech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BTG
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BTG
2.2 - Growth funds investing in similar companies to BTG
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BTG
4.2 - Public trading comparable groups for BTG
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →